Bausch Health Companies Inc. Cash Divested from Deconsolidation
Bausch Health Companies Inc. (BHC) reported Cash Divested from Deconsolidation of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-20.
Discontinued › Cash Flow › Cash
us-gaap:CashDivestedFromDeconsolidation · last filed 2019-02-20
- Bausch Health Companies Inc. cash divested from deconsolidation for the quarter ending 2017-12-31 was $0.00.
- Bausch Health Companies Inc. cash divested from deconsolidation for the quarter ending 2017-09-30 was $0.00.
- Bausch Health Companies Inc. cash divested from deconsolidation for the quarter ending 2017-06-30 was $0.00.
- Bausch Health Companies Inc. cash divested from deconsolidation for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. cash divested from deconsolidation for fiscal 2018 was $0.00.
- Bausch Health Companies Inc. cash divested from deconsolidation for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Bausch Health Companies Inc. cash divested from deconsolidation for fiscal 2016 was $30.00M.
- Bausch Health Companies Inc. cash divested from deconsolidation for fiscal 2014 was $0.00.
| Period end | Cash Divested from Deconsolidation 3 month | Cash Divested from Deconsolidation 3 month as first filed | Cash Divested from Deconsolidation 6 month | Cash Divested from Deconsolidation 6 month as first filed | Cash Divested from Deconsolidation 9 month | Cash Divested from Deconsolidation 9 month as first filed | Cash Divested from Deconsolidation 12 month |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-20 | ||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $0.00 derived: sum of 2 quarters · filed 2019-02-20 | $0.00 derived: sum of 3 quarters · filed 2019-02-20 | $0.00 10-K · filed 2019-02-20 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | $0.00 derived: sum of 3 quarters · filed 2019-02-20 | $0.00 derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-02-20 | $0.00 derived: sum of 3 quarters · filed 2019-02-20 | $0.00 derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $0.00 derived: sum of 2 quarters · filed 2019-02-20 | $0.00 derived: sum of 3 quarters · filed 2019-02-20 | $30.00M 10-K · filed 2019-02-20 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $30.00M 10-Q · filed 2017-11-07 | $30.20M 10-Q · filed 2016-11-09 | $30.00M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $30.00M 10-Q · filed 2017-08-08 | $30.20M 10-Q · filed 2016-08-09 | $30.00M derived: sum of 3 quarters · filed 2018-08-10 | $30.00M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-03-31 | $30.00M 10-Q · filed 2017-05-09 | $30.20M 10-Q · filed 2016-06-07 | $30.00M derived: sum of 2 quarters · filed 2018-08-10 | $30.00M derived: sum of 3 quarters · filed 2018-08-10 | $30.00M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2015-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $0.00 derived: sum of 2 quarters · filed 2018-08-10 | $0.00 derived: sum of 3 quarters · filed 2018-08-10 | $0.00 8-K · filed 2018-08-10 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | ||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | |||||
| 2015-03-31 | $0.00 10-Q · filed 2016-06-07 | ||||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |